top of page

DEEP TECH
INDEPENDENT PROGRAMME
EVALUATION & DESIGN​

Know what to
renew, redesign or stop.

Assess how your programme affects the ventures, and what could not happen without your initiative.

 

I independently test the KPIs, selection criteria, incentives and delivery structure behind your design – defensible to boards, funders and public stakeholders.

​​

Before renewal, redesign or funding.

 

First evidence delivered in 2–3 weeks.

We need to evaluate our innovation programme before the next funding decision. Which outcomes should we measure, and what evidence would make a credible case for continuing or changing the programme?

Innovation Initiative Evaluation & Design:
From Activity to Programme Impact

Your next mandate, funding period or board review is approaching. You can show activity
– but not yet which interventions are changing outcomes.

I INVESTIGATE How programme design, venture selection, incentives, support and founder behaviour connect to the outcomes being claimed.

YOU CAN DECIDE What to renew, redesign, scale or stop – and the evidence required to defend that decision.

​Your deep tech startups portfolio keeps consuming capital, but it is difficult to distinguish
temporary friction from ventures whose route to market is structurally blocked.

I INVESTIGATE How technical readiness, market demand, regulation, adoption, capital requirements, team capacity and timing constrain one another.

YOU CAN DECIDE Which ventures merit more time and capital, which need a different route to market, and which should be stopped before further investment.

You want the strongest ventures, but credible business builders bypass the programme
– or take the funding without valuing the support. Competing offers look largely interchangeable.

I INVESTIGATE How the proposition, selection model, incentives, expertise, funding and assumed scaling route influence who joins and what the programme actually changes.

YOU CAN DECIDE A differentiated offer that stronger ventures choose for reasons beyond free support or grant access.

The evaluation is complete and the recommendation is on paper.
But implementation stalls between organisations, decision owners and reporting cycles.

I INVESTIGATE Which dependencies, decision rights, evidence gates and responsibilities must align for the recommendation to work in practice.

YOU CAN DECIDE A sequence that existing teams can implement: who decides what, what happens next and what must become true before further commitment.

INAM:
what the KPIs incentivize

“Arise Innovations conducted an analysis of our Advanced Materials Competition accelerator programme that helped identify a previously unclear bottleneck: how our KPI architecture shapes venture behavior – and where that creates mid-term risk. This is a different layer and quality of input than operational feedback and gave us a concrete basis to rethink what we actually want to incentivize. We recommend Arise Innovations to any programme operator or ecosystem that wants to understand if their current structure is built to produce the desired outcomes - not just how well it is being executed.”

– Oliver Hasse, Innovation Network for Advanced Materials

Evaluate, Design & Fund Lab-to-Market Initiatives

1

Decision Review

Identify the binding constraint, test the evidence and set explicit conditions to continue, change or stop. For programme leaders, funders and institutional sponsors.

​

For one consequential decision that cannot safely be made on current evidence.

You receive:

→ an independent assessment of the decision

→ the binding constraint and material evidence gaps

→ explicit conditions to continue, change or stop

→ a 3–5 page executive decision brief

 

​

Process: Document review, up to three stakeholder conversations, written assessment and leadership readout. Timeline: 2–3 weeks.​

Portfolio Diagnostic

Examine selection, support, evidence and progression logic; identify structural gaps and redesign priorities before the next funding or programme cycle.

​​​

For programme or portfolio leaders who need to decide what to retain, change or stop before the next cycle.

You receive:

→ assessment of selection, support and progression logic

→ identification of structural gaps and portfolio risks

→ prioritised recommendations

→ a 10–12 page diagnostic and executive decision brief

 

​

Process: Evidence review, selected stakeholder interviews, portfolio analysis and leadership readout. Timeline: 4–6 weeks.​

2

3

Infrastructure Setup

Define evidence standards, review gates and decision records that help teams allocate support and capital consistently across a programme or portfolio.

​

For institutions that want to embed consistent decision quality across a programme or portfolio.

You receive:

→ evidence standards and decision gates

→ renewal, escalation and exit conditions

→ decision records and governance routines

→ implementation guidance for internal teams

​

Process: Scoped from an existing diagnostic or a defined institutional decision problem.

Timeline: 8–12 weeks

imi

Decisions changed

A busy programme is not necessarily moving ventures closer to market. The cases examine how selection, incentives, support and timing can enable progress – or obstruct the work teams need to do next. Discover how QUATISE diagnoses the mismatch and develops targeted changes within existing structures and constraints. Download a case to see what could change, why it matters and how to assess whether the programme adds value beyond the venture’s independent route.

Heisenberg's Uncertainty in Venture Building.png

INDUSTRIAL QUALIFICATION PROGRAMME

Protect the evidence work inside a shared programme

An accelerator wants to improve venture progression through a common curriculum, but its teams need different laboratory tests, industrial validation and customer evidence.

Underlying issue: Uniform attendance requirements can displace the very work needed for a team’s next decision. Programme activity may increase while the decisive uncertainty remains unresolved.

Risk reduction: QUATISE identifies where substitution is justified and defines an authorised evidence task, owner and review gate within the existing programme. Compared with continuing the same calendar for everyone, this can protect critical work while retaining useful shared support.

Newsletter
Briefs

Analysis of the decisions connecting science, commercialisation, capital and policy.

Each brief examines a consequential question, the evidence behind it and what it could change about the next move.

bottom of page